Researchers have found that, in asymptomatic patients, atherosclerosis and its progression are independently associated with all-cause mortality.

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Cardiovascular disease deaths increased by about 21% for adults ages 25–64 living in rural areas between 2010 and 2022, however, the rate declined by 9% for adults ages 65 or older living in urban ...